topSkip to main content

Menu, Secondary

Menu Trigger

Menu

Emory University

The University of California San Diego has joined a Phase II clinical trial to evaluate various additional COVID-19 booster shots. The trial seeks to understand if different vaccine regimens can broaden immune responses in adults who already have received a primary vaccination series and a first booster shot.
An expansion of the Emory Advantage program will eliminate need-based loans as part of undergraduate students’ financial aid packages, replacing them with institutional grants and scholarships beginning this fall for the 2022-23 academic year.
Emory University has developed a sensitive and specific diagnostic antibody blood test that will help determine antibody responses in people who have been infected by COVID-19.
Human clinical trials may begin on an antiviral compound which was discovered and developed by Emory University and shows promise as a potential treatment for COVID-19.
Emory doctors have helped create a new online tool allowing people everywhere to assess how likely it is that they have contracted the novel coronavirus.
Emory University will take part in an NIH-sponsored global clinical trial to evaluate the safety and efficacy of novel therapeutic agents in hospitalized adult patients diagnosed with COVID-19.
An Emory University study shows that males gain a slight advantage in mental-rotation performance during the first years of formal schooling, and this advantage slowly grows with age, tripling in size by the end of adolescence.
A nationwide consortium of researchers has identified the first genetic defect linked to biliary atresia, a mysterious liver disease that is the leading cause for liver transplantation in children.
A new screening method using sensor particles and a urine test could catch organ transplant rejection much earlier, more comprehensively, and without a biopsy needle.
Exercise remains the most common practice among nationally tracked persons who are able to maintain weight loss over time.